Reteplase has recently been used for peripheral thrombolysis. Reteplase can be diluted in sterile water to 0.04 U/mL and remains stable for 24 hours. No prospective dosage trials for this agent ...

Reteplase (Retavase®, Centocor Inc., Mavern, PA, USA) is a third-generation thrombolytic that has a longer half-life and better penetration into a thrombus compared with rt-PA. [22] However ...